Recall of Bextra

After careful studies of the risk of not only heart attack and strokes, but also the frequency of potentially fatal allergic skin reactions, the FDA re-evaluated Bextra and on April 7, 2005, they asked Pfizer to remove Bextra from American and European markets. Widespread prescriptions of Bextra had already caused significant damage, and may victims of the drug's side effects continue to suffer from the terrible consequences.